Leo Grady’s Jona Hopes To Repair Microbiome Testing’s Murky Reputation
Executive Summary
After leading Paige to success with the FDA, Grady has turned his attention to the microbiome. He hopes his new company, Jona, will be able to provide detailed insights to doctors, their patients and pharmaceutical players.
You may also be interested in...
Octave Biosciences Takes It Up Another Semitone With Michael J Fox Foundation Grant
The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.
Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with Abbott’s head of Lingo Biowearables and top executives at Twin Health. Reed Miller provides an update on J&J MedTech’s launch of the Ottava soft-tissue robotic surgery system and Barnaby Pickering talks about his recent interview with Leo Grady, former CEO of Paige AI, to talk about his new start-up Jona.
News We’re Watching: Abbott FreeStyle Libre Recall, Medtronic Partners With DaVita, Free SBOM Software
This week, Abbott announced a class I recall of several glucose management systems. Additionally, Medtronic announced partnerships with DaVita and Qure.Ai; Heartflow closed a funding round; and BiVacor readies for artificial heart trials.